To access the full text documents, please follow this link: http://hdl.handle.net/2445/18677
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Llovet i Bayer, Josep Maria |
dc.contributor.author | Mas, X. |
dc.contributor.author | Aponte, John J. |
dc.contributor.author | Fuster Obregón, Josep |
dc.contributor.author | Navasa, Miquel |
dc.contributor.author | Christensen, E. |
dc.contributor.author | Rodés, J. |
dc.contributor.author | Bruix Tudó, Jordi |
dc.date | 2011-07-07T12:31:00Z |
dc.date | 2011-07-07T12:31:00Z |
dc.date | 2002 |
dc.identifier.citation | 0017-5749 |
dc.identifier.citation | 544216 |
dc.identifier.uri | http://hdl.handle.net/2445/18677 |
dc.format | 6 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | BMJ Group |
dc.relation | Reproducció digital del document publicat a: http://dx.doi.org/10.1136/gut.50.1.123 |
dc.relation | Gut, 2002, vol. 50, núm. 1, p. 123-128 |
dc.relation | http://dx.doi.org/10.1136/gut.50.1.123 |
dc.rights | (c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2002 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Trasplantament hepàtic |
dc.subject | Anàlisi cost-benefici |
dc.subject | Càncer de fetge |
dc.subject | Hepatic transplantation |
dc.subject | Cost effectiveness |
dc.subject | Liver cancer |
dc.title | Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |